ECG Signal Characterization for Precise QT Interval Measurement
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for conducting Thorough QT (TQT) studies face challenges in obtaining precise electrocardiogram (ECG) measurements due to poor signal quality and variability, leading to inconclusive results and potential false positives, which can result in drug withdrawals or safety warnings.
Innovation Solution
The described method involves characterizing ECG signals by identifying evaluable multi-beat sequences based on signal-to-noise ratio (SNR) and heart rate stability, excluding non-sinus beats and noise, and using automated processing levels to determine accurate QT interval measurements, thereby improving precision and accuracy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional ECG measurement methods are used in TQT studies, then the study can be conducted with standard procedures, but the measurement precision and reliability are insufficient leading to inconclusive results
Solution Approach 1:
The patent segments the ECG signal analysis into multiple discrete steps: quality assessment, beat selection, interval measurement, and confidence interval calculation. By dividing the measurement process into separable stages with specific criteria at each step, the system achieves higher precision and reliability in QT interval measurements compared to traditional black-box ECG analysis methods.
Solution Approach 2:
The patent changes multiple parameters in the ECG analysis process including signal quality thresholds, beat selection criteria, measurement time points, and confidence interval calculations. By systematically adjusting and optimizing these parameters, the method achieves superior measurement precision and reliability for determining drug-induced QT prolongation.
2Measurement precision
If more subjects are enrolled in TQT studies to compensate for imprecise measurements, then the statistical power increases, but the study cost and complexity increase
Solution Approach 1:
The patent replaces the mechanical approach of increasing subject numbers to compensate for measurement imprecision with an automated computational system. The computer-implemented method uses algorithms to assess signal quality, select appropriate beats, and calculate confidence intervals, substituting computational precision for statistical power derived from larger sample sizes.
3Measurement precision
If automated processing is used to reduce human variability in ECG measurement, then measurement consistency improves, but the complexity of the automated system increases
Solution Approach 1:
The automated ECG analysis system performs self-assessment of signal quality, automatic beat selection, and independent calculation of confidence intervals without requiring manual intervention. The system serves itself by implementing built-in quality control mechanisms and automated decision-making algorithms, achieving measurement consistency while managing complexity through self-contained processing.
4Measurement precision
If comprehensive quality assessment and filtering of ECG data is performed, then the accuracy of QT interval measurements improves, but the processing time and computational resources increase
Solution Approach 1:
The patent performs preliminary quality assessment and beat selection before the actual QT interval measurement. By pre-filtering the ECG data based on signal quality criteria and selecting only suitable beats for analysis, the system prepares the data in advance, ensuring measurement accuracy while reducing the computational burden during the final measurement stage.
Data Source
AI summary
Described here are methods, devices, and systems for characterizing a physiological signal, and more specifically an electrocardiogram (ECG) signal. Generally, the method includes receiving an ECG signal generated by an ECG device coupled to a patient. The ECG signal may comprise a plurality of cardiac beat intervals. A set of evaluable replicates may be identified using a signal-to-noise ratio (SNR) for each cardiac beat, a repolarization signal, and an isoelectric line. Interval measurements may be determined from the set of evaluable multi-beat sequences. An ECG signal characteristic may be determined from the interval measurements.